Analytical Data
-
Gene name
FAM64A
- Application
-
Alternative Names
FA64A_HUMAN; FAM64A; family with sequence similarity 64; member A; FLJ10156; FLJ10491; Protein FAM64A; RCS1; regulator of chromosome segregation 1
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9BSJ6
-
Expression Region
1-248aa
-
AA Sequence
MASRWQNMGTSVRRRSLQHQEQLEDSKELQPVVSHQETSVGALGSLCRQFQRRLPLRAVNLNLRAGPSWKRLETPEPGQQGLQAAARSAKSALGAVSQRIQESCQSGTKWLVETQVKARRRKRGAQKGSGSPTHSLSQKSTRLSGAAPAHSAADPWEKEHHRLSVRMGSHAHPLRRSRREAAFRSPYSSTEPLCSPSESDSDLEPVGAGIQHLQKLSQELDEAIMAEERKQALSDRQGFILKDVYASP
-
Molecular Weight
53.9 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FAM64A, a gene located on human chromosome 19, encodes a protein that is implicated in various cellular processes, including cell proliferation, differentiation, and apoptosis. Recent studies have highlighted the potential role of FAM64A in cancer biology, as altered expression levels of this protein have been associated with tumorigenesis and cancer progression. The protein is believed to interact with key regulatory pathways that control cell cycle dynamics and cellular stress responses. Furthermore, FAM64A has been identified as being involved in the maintenance of genomic stability, making it a critical factor in understanding tumor development and metastasis. Given its significance in cancer, recombinant FAM64A proteins are being studied for their potential use in therapeutic applications and as diagnostic markers. Research has focused on elucidating its structural features, functional mechanisms, and interactions with other cellular components, thereby paving the way for targeted treatments aimed at modulating FAM64A activity in cancer cells. As a result, FAM64A represents a promising target for further investigation, with the potential to contribute to personalized medicine approaches in oncology.











